Wearable MEG - Using novel technology to improve surgeryoutcome in epilepsy patients

etherlands Epilepsy Foundation (NEF)0 个研究点目标入组 7 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Patients have refractory epilepsy (not responding to treatment with anti-epileptic
•drugs) and are candidates for epilepsy surgery at VUmc (adults) or UMCU (children).
•- We include adults (VUmc) or children of six years of age or older (UMCU).
•- Patients have already undergone a clinical SQUID-based MEG and dEEG at VUmc
•- 3 patients: confirmed focal source on dEEG of mesial temporal origin
•- 1 patient: frequent seizures (~daily)
•- Six years of age or older
•- Patients have already undergone a clinical SQUID-based MEG with simultaneous
•scalp-EEG at VUmc
•- Confirmed focal source of epileptiform activity in clinical MEG or EEG

•- Already undergone surgery for their current epilepsy
•- The patients have already undergone a clinical SQUID-based MEG. Those patients
•who had claustrophobic or anxiety experiences from being enclosed in the
•magnetically shielded room will be excluded
•- Patients with many artefacts, related to either movement (restlessness, i.e. not
•seizure-related) or metal implants (not MEG compatible), on their clinical SQUIDbased

发起方

etherlands Epilepsy Foundation (NEF)